Abstract
Mucormycosis is a devastating infection in diabetics that has high mortality and requires prolonged treatment with amphotericin B and surgery. The majority of mucormycosis in diabetics is sinus-related disease that may spread to contiguous structures including the face, orbit, and cerebrum. Early diagnosis of mucormycosis is challenging because patients often present with subtle findings. Clinicians should have a high degree of suspicion in patients who present with diabetic ketoacidosis or poorly controlled diabetes and have findings suggestive of disease that involves the sinus, eyes, face, cranial nerves, or altered mental status. Diagnosis is made from tissue scrapings of lesions, tissue biopsy, endoscopic examination, fungal culture, and characteristic tissue histology. Urgent intervention with antibiotics and surgery improves clinical outcomes, but despite appropriate therapy a significant number of patients will die or be disfigured.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.
Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17(12):1859–67.
Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44(4):335–42.
Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. Sep 2009;15(9):1395–401.
Kontoyiannis DP, Lewis RE, editors. Agents of mucormycosis and entomophthoramycosis. In: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, No. 2. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010.
Ibrahim AS, Gebremariam T, Lin L, et al. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. Aug 2010;77(3):587–604.
Speert DP, Silva Jr J. Abnormalities of in vitro lymphocyte response to mitogens in diabetic children during acute ketoacidosis. Am J Dis Child. Oct 1978;132(10):1014–7.
Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39(1):3–22.
Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis. Apr 2011;11(4):301–11.
van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61–5.
Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47(3):364–71.
Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Doggett, J.S., Wong, B. (2014). Mucormycosis. In: Loriaux, L. (eds) Endocrine Emergencies. Contemporary Endocrinology, vol 74. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-697-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-62703-697-9_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-696-2
Online ISBN: 978-1-62703-697-9
eBook Packages: MedicineMedicine (R0)